IL10 and neoplasm: Additionally, emerging bioengineering strategies aim to enhance IL-10’s therapeutic potential by improving its stability, half-life, pharmacokinetics, and targeted-delivery and specificity to tumor sites, showing promising results in the preclinical studies.